Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Pei Shu

Continuous Targeted Kinase Inhibitors Treatment Induces Upregulation of PD-L1 in Resistant NSCLC

Scientific Reports

Multidisciplinary

English

Related publications

Pcp61 - Evidence-Based Value of Pd-1 / Pd-L1 Inhibitors in Nsclc: Comparison of Value to Price

Value in Health

Occupational Health

English

Immunotherapies Based on PD-1/PD-L1 Pathway Inhibitors in Ovarian Cancer Treatment

Clinical and Experimental Immunology

English

PD-L1-Hemmer Bei Vorbehandelten Patienten Mit NSCLC

Im Focus Onkologie

English

NSCLC: Zwei Positive Studien Zu PD-L1-Hemmer

Im Focus Onkologie

English

MA09.09 EBUS-TBNA in Assessing PD-L1 Expression in NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

45. A Retrospective Assessment of PD-L1 Expression Rates in NSCLC

Forensic Medicine

English

NSCLC: Atezolizumab Mit Überlebensvorteil Unabhängig Vom PD-L1-Status

Respiratory Medicine

English

Design of PD-L1 Inhibitors for Lung Cancer

English

Aspirin‐targeted PD‐L1 in Lung Cancer Growth Inhibition

Thoracic Cancer

Respiratory Medicine

English